Okomera
Paris
About Okomera
Okomera is a biotech start-up that accelerates access to more effective, precision-based cancer medicines. It pioneered the automation and downsizing of individualized tumor biopsy research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.8M
- Funding stage: Seed
- Last round: Grant (Oct 2024)
- Website: okomera.com
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/okomera-10440 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.